Intermittent Androgen Deprivation: Primum Non Nocere-"First Do NO Harm"

JAMA Oncol. 2016 Dec 1;2(12):1533-1534. doi: 10.1001/jamaoncol.2016.2650.

Authors

Maha Hussain¹, Mario Eisenberger²

Affiliations

¹ Departments of Internal Medicine and Urology, University of Michigan, Ann Arbor.
² Johns Hopkins Sidney Kimmel Cancer Center, Oncology, Baltimore, Maryland.

PMID: 27560843
DOI: 10.1001/jamaoncol.2016.2650

No abstract available

MeSH terms

Androgen Antagonists / therapeutic use*
Androgens / metabolism*
Clinical Trials as Topic
Disease-Free Survival
Humans
Male
Neoplastic Stem Cells / drug effects
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / metabolism
Prostatic Neoplasms / pathology
Treatment Outcome

Substances

Androgen Antagonists
Androgens